Merck Selling Its Federally-financed Covid Pill to the US for 40 Times What it Costs to Make

Sharing is Caring!

by Chris Black

Merck is manufacturing molnupiravir at a cost of $17.74 per five-day course but charging the US government $712 for the same amount of medicine, according to a joint report by drug-pricing experts at Harvard and King’s College Hospital in London.

That’s 40 times the price for the pill that is said to cut the risk of hospitalization with Coronavirus in half, The Intercept says.

To add insult to injury, the US government spent at least $29 million on the drug’s development — $10 million from the DoD and a further $19 million from the National Institutes of Health.

See also  Moderna is planning to dramatically raise the price of its COVID vaccine.
See also  "A 700,000 person study from Israel showed that the double vaccinated were 27 times more likely to get reinfected with COVID, and data from England, Scotland, and northern countries in Europe show tripled vaccinated were more likely to die.” - Richard Urso MD

Views: 7

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.